CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system

FHS
August 16, 2023
10:42 am

A gamified tool to estimate infection risks associated with day-to-day activities during the COVID-19 pandemic.

Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says

Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up were higher than expected, but the vaccine’s benefits

June 1, 2024

Topical Nonsteroid Gets High Marks for Youngsters With Atopic Dermatitis

SAN DIEGO — Once-daily topical therapy for small children with atopic dermatitis (AD) produced rapid improvement with good tolerability, a large randomized trial showed. Evidence

March 16, 2024

Tariffs on medical items should be reinvested in the health care supply chain

For supply chains, natural and manmade disruptive events act like a domino effect, impacting an organization’s operations, bottom line, and the delivery of products and

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.